BiotechTube
Home/MitoSense/Catherine Baucom, MD, PhD
CB

Catherine Baucom, MD, PhD

Chief Medical Officer

MitoSense

Therapeutic Areas

Neurodegenerative Diseases

MitoSense Pipeline

DrugIndicationPhase
MOT™ for ALSAmyotrophic Lateral Sclerosis (ALS)Pre-clinical
MOT™ PlatformAlzheimer's Disease, Parkinson's Disease, Huntington's Disease, Multiple SclerosisResearch/Discovery

Leadership Team at MitoSense

BS
Brent Segal, PhD
Chief Executive Officer
VH
Van Hipp
Chairman
XP
Xian Peng Jiang
Chief Scientific Officer
RW
Rick Waldo
Board Member
View full MitoSense profile